BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

Investigators at the Jacobs School of Medicine and Biomedical Sciences have uncovered how heat causes a critical receptor protein within cells to unfold and relay pain, which could open up new ...

Northwestern Medicine investigators have discovered new mechanisms underlying cellular adhesion and repair, findings that ...

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

Mal-ID – can decipher an individual’s immune system’s record of past infections and diseases, according to a new study, providing a powerful tool with the potential for diagnosing autoimmune disorders ...

The FDA granted Regenerative Medicine Advanced Therapy designation to NXC-201 for the treatment of relapsed/refractory light ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.